2nd Canadian Peptide and Protein Community Virtual Meeting

Canadian Peptide and Protein Community;Department of Chemistry, Université de Montréal;Professor William D. Lubell studies medicinal chemistry and peptide science by the innovation of peptides and peptidomimetics that target and modulate biologically relevant receptors for drug discovery (www.wdlubellgroup.com). Co-author of >250 scientific publications, former Associate Editor of Organic Letters (2005-2018), editorial board member of journals in the biomedical sciences, and innovator of intellectual property used to launch start-up companies, Lubell received the 2013 Canadian Society for Chemistry Bernard Belleau and the 2018 Teva Canada Limited Biological and Medicinal Chemistry Lectureship Awards. Forging collaborations with biochemists, pharmacologists and physicians, his efforts are critical in drug discovery teams developing interventions to treat Alzheimer’s disease, premature birth, an unmet-medical need with the highest cost per patient, and age-related macular degeneration, the leading cause of adult blindness. Originator of Molecules of Life (www.moleculesoflife.ca) and co-author of the Molecular Marvels of Superheroes Series, Lubell explores experiential education techniques to teach the public about science.

Canadian Peptide and Protein Community;Faculté de pharmacie de l’Université Laval;Centre de recherche du CHU de Québec-Université Laval,;

Canadian Peptide and Protein Community;Department of Chemistry, University of Toronto;

Canadian Peptide and Protein Community;Chemistry Department, Western University;Dr. Len Luyt received his Ph.D. in Chemistry from Western University and subsequently undertook a post-doctoral fellowship with Prof. John Katzenellenbogen at the University of Illinois, Urbana-Champaign. He then led a research team as a Senior Medicinal Chemist with the pharmaceutical company Bayer-Schering. Dr. Luyt joined Western University in 2005 as a faculty member with appointments in the Departments of Chemistry, Oncology and Medical Imaging, and was promoted to full Professor in 2020. The research program of Dr. Luyt spans from basic chemistry activities, looking at novel methods of incorporating metal complexes into peptide structures, through to applied research, investigating new peptide therapeutics and molecular imaging agents for novel cancer targets.

Canadian Peptide and Protein Community;Department of Chemistry, University of British Columbia;

Canadian Peptide and Protein Community;Department of Chemistry, University of Toronto;

Canadian Peptide and Protein Community;Department of Chemistry, Carleton University;Dr. David Sabatino performs research interfacing nucleic acid and peptide chemical biology. Aiming to develop novel anti-cancer agents, Dr. Sabatino is exploring original synthetic RNA- and peptide-based agents for gene and immune therapy. Mentor of over 60 students, co-author of more than 40 peer-reviewed scientific publications, conference proceedings, patents and a book chapter, Dr. Sabatino has delivered over 70 conference presentations at regional, national, and international meetings. The Sabatino laboratory has benefited from support from federal government funding agencies in the USA (NIH/NCI) and Canada (NSERC and CFI) to preform research oriented on the development of anti-cancer treatment strategies. Nominated Researcher of the Year at Seton Hall University in 2019, Dr. Sabatino was recruited to the Department of Chemistry at Carleton University in 2022.

Canadian Peptide and Protein Community;Département de chimie, Université du Québec à Montréal;

Canadian Peptide and Protein Community;School of Biomedical Engineering, Faculty of Medicine, University of Prince Edward Island;

Canadian Peptide and Protein Community;Armand-Frappier Santé Biotechnologie Research Centre;

Canadian Peptide and Protein Community;BridGene Biosciences, San Jose, CA.;